Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06935253 · ClinicalTrials.gov registry record · NA
Large Language Models To Improve the Quality of Care of Cardiology Patients
A NA study of Genetic Disease and Cardiomyopathy, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06935253: Recruiting NA study of Genetic Disease and Cardiomyopathy, sponsored by Stanford University.
NCT06935253 is a NA study of Genetic Disease and Cardiomyopathy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 12 participants, below the 2,561-participant average among 30 other Genetic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06935253, a NA study of Genetic Disease and Cardiomyopathy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the impact of large language models (LLMs) versus traditional decision support tools on clinical decision-making in cardiology. General cardiologists will be randomized to manage real patient cases from a cardiovascular genetic cardiomyopathy clinic, with or without AI assistance. Each case will be assessed by two cardiologists, and their responses will be graded by blinded subspecialty experts using a standardized evaluation rubric.
Primary Outcome
The primary outcome is the preference of the subspecialist between answers provided by a) Cardiologist with access to Large Language Model vs. b) Cardiologist without access to Large Language Model.
Conditions Studied
Interventions
- OTHER Large Language Model
Study Locations (1)
California
- Stanford - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06935253 shows while recruiting
NCT06935253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 2,561-participant average among 30 other Genetic Disease trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Large Language Model is the first listed.
NCT06935253 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06935253 about?
NCT06935253 is a clinical study titled "Large Language Models To Improve the Quality of Care of Cardiology Patients". This study evaluates the impact of large language models (LLMs) versus traditional decision support tools on clinical decision-making in cardiology. General cardiologists will be randomized to manage real patient cases from a cardiovascular genetic cardiomyopathy clinic, with or without AI assistanc...
What is the current status of trial NCT06935253?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-01-10. Estimated completion is 2025-12.
What conditions does trial NCT06935253 study?
This clinical trial studies the following conditions: Genetic Disease, Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Cardiology.
What interventions are being tested in trial NCT06935253?
The interventions under investigation include: Large Language Model (OTHER).
Who is sponsoring clinical trial NCT06935253?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06935253 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06935253's enrollment target sits among peer trials
12 27th of 30 higher than 4 of 30 other Genetic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Grand Valley State University (GVSU) Skills on Wheels
ACTIVE NOT RECRUITING · NA
-
Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
ACTIVE NOT RECRUITING · NA
-
The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI